MiR-19a Affects Hepatocyte Autophagy via Regulating lncRNA NBR2 and AMPK/PPARα in D-GalN/Lipopolysaccharide-Stimulated Hepatocytes

J Cell Biochem. 2018 Jan;119(1):358-365. doi: 10.1002/jcb.26188. Epub 2017 Jul 24.

Abstract

This study aims to evaluate the potential involvement and regulatory mechanism of miR-19a in hepatocytes autophagy of acute liver failure (ALF). The in vitro hepatocytes injury model of primary hepatocyte and hepatocytes line HL-7702 was established by D-galactosamine (D-GalN) and lipopolysaccharide (LPS) co-treatment. Relative expression level of miR-19a and NBR2 was determined by qRT-PCR. Protein expression of AMPK/PPARα and autophagy-related gene was determined by Western blot. In hepatic tissue of 20 ALF patients and D-GalN/LPS-stimulated hepatocytes, miR-19a was upregulated and NBR2 was downregulated. D-GalN/LPS stimulation caused the inactivation of AMPK/PPARα signaling and the decrease of autophagy-related LC3-II/LC3-I ratio and beclin-1 expression in hepatocytes. The expression of both AMPK/PPARα and NBR2 were negatively controlled by miR-19a overexpression or knockdown. Moreover, both NBR2 and PPARα were targeted regulated by miR-19a according to luciferase reporter assay. In D-GalN/LPS-stimulated hepatocytes, AMPK activation promoted PPARα expression. AMPK inactivation inhibited the pro-autophagy effect of miR-19a and caused the decrease of LC3-II/LC3-I ratio and beclin-1 expression. PPARα activation abrogated the anti-autophagy effect of miR-19a mimic and caused the increase of LC3-II/LC3-I ratio and beclin-1 expression. NBR2 knockdown reversed the anti-autophagy impact of miR-19a inhibitor and caused the decrease of LC3-II/LC3-I ratio and beclin-1 expression. In summary, our data suggested that miR-19a negatively controlled the autophagy of hepatocytes attenuated in D-GalN/LPS-stimulated hepatocytes via regulating NBR2 and AMPK/PPARα signaling. J. Cell. Biochem. 119: 358-365, 2018. © 2017 Wiley Periodicals, Inc.

Keywords: ACUTE LIVER FAILURE; AMPK/PPARα; AUTOPHAGY; NBR2; miR-19a.

MeSH terms

  • AMP-Activated Protein Kinase Kinases
  • Autophagy / drug effects*
  • Cell Line
  • Galactosamine / toxicity*
  • Hepatocytes / metabolism*
  • Hepatocytes / pathology
  • Humans
  • Lipopolysaccharides / toxicity*
  • Liver Failure, Acute / metabolism
  • Liver Failure, Acute / pathology
  • MicroRNAs / metabolism*
  • PPAR alpha / metabolism*
  • Protein Kinases / metabolism*
  • RNA, Long Noncoding / metabolism*
  • Signal Transduction / drug effects*

Substances

  • Lipopolysaccharides
  • MIRN19 microRNA, human
  • MicroRNAs
  • PPAR alpha
  • RNA, Long Noncoding
  • Galactosamine
  • Protein Kinases
  • AMP-Activated Protein Kinase Kinases